Chun‐Mei Hu

1.1k total citations
48 papers, 778 citations indexed

About

Chun‐Mei Hu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Chun‐Mei Hu has authored 48 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Immunology. Recurrent topics in Chun‐Mei Hu's work include Radiation Effects in Electronics (8 papers), Pancreatic and Hepatic Oncology Research (5 papers) and VLSI and Analog Circuit Testing (5 papers). Chun‐Mei Hu is often cited by papers focused on Radiation Effects in Electronics (8 papers), Pancreatic and Hepatic Oncology Research (5 papers) and VLSI and Analog Circuit Testing (5 papers). Chun‐Mei Hu collaborates with scholars based in Taiwan, China and United States. Chun‐Mei Hu's co-authors include Wen‐Hwa Lee, Yung‐Ming Jeng, Yu‐Ting Chang, Ming‐Chu Chang, Qiusha Tang, Jiewen Zhu, A. Richard Chamberlin, Xiaolong Qiu, Yinan Ding and Zhiyuan Zhang and has published in prestigious journals such as Nature Communications, PLoS ONE and Cell Metabolism.

In The Last Decade

Chun‐Mei Hu

43 papers receiving 766 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chun‐Mei Hu Taiwan	16	395	225	160	138	109	48	778
Jiayi Qian China	15	530 1.3×	130 0.6×	180 1.1×	63 0.5×	114 1.0×	55	864
Gudrun Dandekar Germany	13	341 0.9×	362 1.6×	105 0.7×	150 1.1×	218 2.0×	31	840
Jiani Huang China	16	507 1.3×	161 0.7×	196 1.2×	165 1.2×	178 1.6×	28	1.0k
Beilei Liu China	10	382 1.0×	291 1.3×	170 1.1×	160 1.2×	143 1.3×	20	883
Samad Muhammadnejad Iran	15	272 0.7×	263 1.2×	124 0.8×	98 0.7×	133 1.2×	58	763
Hamed Manoochehri Iran	16	392 1.0×	216 1.0×	237 1.5×	114 0.8×	117 1.1×	52	945
Fangwei Xie China	15	367 0.9×	265 1.2×	165 1.0×	52 0.4×	105 1.0×	26	695
Hailong Xie China	17	340 0.9×	95 0.4×	149 0.9×	92 0.7×	62 0.6×	45	637
Junjun Chu China	16	608 1.5×	256 1.1×	312 1.9×	190 1.4×	74 0.7×	23	1.0k
Mayur Vilas Jain Sweden	13	463 1.2×	278 1.2×	163 1.0×	84 0.6×	171 1.6×	16	883

Countries citing papers authored by Chun‐Mei Hu

Since Specialization

Citations

This map shows the geographic impact of Chun‐Mei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Mei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Mei Hu more than expected).

Fields of papers citing papers by Chun‐Mei Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Mei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Mei Hu. The network helps show where Chun‐Mei Hu may publish in the future.

Co-authorship network of co-authors of Chun‐Mei Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐Mei Hu. A scholar is included among the top collaborators of Chun‐Mei Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐Mei Hu. Chun‐Mei Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Chun‐Mei, et al.. (2025). Innovative cyclic peptide disrupts IL-17RB–MLK4 interaction for targeted pancreatic cancer therapy. Biomedicine & Pharmacotherapy. 184. 117892–117892.

Shih, Mei Fen, et al.. (2025). RRM1 O-GlcNAcylation inhibition suppresses pancreatic cancer via TK1-mediated replication stress. Cancer Gene Therapy. 32(5). 550–562.

Wu, Shengyang, et al.. (2024). Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK. Communications Biology. 7(1). 843–843. 5 indexed citations

Chen, Chien‐Chia, et al.. (2024). Tacrolimus regulates extracellular vesicle secretion from T cells via autophagy-lysosomal pathway. Biomedicine & Pharmacotherapy. 182. 117765–117765.

Lai, Ting‐Yu, Chih‐Yuan Lee, Ting‐Chun Kuo, et al.. (2024). Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors. British Journal of Cancer. 130(7). 1096–1108. 7 indexed citations

Chang, Yu‐Ting, et al.. (2024). Exosomal miRNA 16-5p/29a-3p from pancreatic cancer induce adipose atrophy by inhibiting adipogenesis and promoting lipolysis. iScience. 27(7). 110346–110346. 3 indexed citations

Chen, Y.M., et al.. (2024). SEMA7A-mediated juxtacrine stimulation of IGFBP-3 upregulates IL-17RB at pancreatic cancer invasive front. Cancer Gene Therapy. 31(12). 1840–1855. 1 indexed citations

Hu, Chun‐Mei, Chien‐Chang Huang, Hung‐Jen Chien, et al.. (2023). Oncogenic KRAS, Mucin 4, and Activin A‐Mediated Fibroblast Activation Cooperate for PanIN Initiation. Advanced Science. 10(36). e2301240–e2301240. 2 indexed citations

Liu, Yu-Huei, et al.. (2022). Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma. Cell Death and Disease. 13(9). 817–817. 27 indexed citations

10.

Chen, Y.M., Yung‐Ming Jeng, Yu‐Wen Tien, et al.. (2022). Homophilic ATP1A1 binding induces activin A secretion to promote EMT of tumor cells and myofibroblast activation. Nature Communications. 13(1). 2945–2945. 25 indexed citations

11.

Chen, Xiaorui, I-Ju Liu, Chun‐Mei Hu, et al.. (2022). Structural basis of interleukin-17B receptor in complex with a neutralizing antibody for guiding humanization and affinity maturation. Cell Reports. 41(4). 111555–111555. 2 indexed citations

12.

Wu, Heng‐Hsiung, Pang‐Hung Hsu, Mei‐Yu Chen, et al.. (2021). Characterization of initial key steps of IL-17 receptor B oncogenic signaling for targeted therapy of pancreatic cancer. Science Translational Medicine. 13(583). 17 indexed citations

13.

An, Yanli, Rui Yang, Xihui Wang, et al.. (2021). Facile Assembly of Thermosensitive Liposomes for Active Targeting Imaging and Synergetic Chemo-/Magnetic Hyperthermia Therapy. Frontiers in Bioengineering and Biotechnology. 9. 691091–691091. 12 indexed citations

14.

Stoddart, Angela, Jianghong Wang, Anthony A. Fernald, et al.. (2020). Cytotoxic Therapy–Induced Effects on Both Hematopoietic and Marrow Stromal Cells Promotes Therapy-Related Myeloid Neoplasms. Blood Cancer Discovery. 1(1). 32–47. 22 indexed citations

15.

Hsu, Jye‐Lin, Jen‐Wei Chou, Joung‐Liang Lan, et al.. (2019). Glutathione peroxidase 8 negatively regulates caspase‐4/11 to protect against colitis. EMBO Molecular Medicine. 12(1). e9386–e9386. 44 indexed citations

16.

Wei, Pei‐Chi, Wendy W. Hwang‐Verslues, Wen‐Hung Kuo, et al.. (2017). TGF‐β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up‐regulation of IL‐17RB. EMBO Molecular Medicine. 9(12). 1660–1680. 49 indexed citations

17.

Yeh, Hsi-Wen, et al.. (2017). Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis. Oncotarget. 8(44). 77734–77751. 32 indexed citations

18.

Zhu, Jiewen, Longen Zhou, Guikai Wu, et al.. (2013). A novel small molecule RAD51 inactivator overcomes imatinib‐resistance in chronic myeloid leukaemia. EMBO Molecular Medicine. 5(3). 353–365. 74 indexed citations

19.

Hu, Chun‐Mei. (2007). Present State and Perspectives about the Technique of Rotating and Percussive Drilling. Oil Field Equipment. 2 indexed citations

20.

Shuhua, Xiao, Peter J. Hotez, Qiyang Li, et al.. (1999). Epidemiology of human ancylostomiasis among rural villagers in Nanlin County (Zhongzhou village), Anhui Province, China: age-associated prevalence, intensity and hookworm species identification.. PubMed. 30(4). 692–7. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact